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Abstract
Background: Diabetic retinopathy (DR) is one of the leading causes of blindness. The aim of this
study was to estimate the prevalence and determinants of retinopathy among diabetics in Al-Ain
city, United Arab Emirates (UAE).
Methods: The study was part of a general cross-sectional survey carried out to assess the
prevalence of diabetes (DM) complications including retinopathy among known diabetic patients in
Al-Ain District, UAE. Patients were randomly selected during 2003/2004. Patients completed an
interviewer-administered questionnaire carried out by treating doctors and underwent a complete
medical assessment. All patients were examined for evidence of diabetic retinopathy by
ophthalmologist and their fundi were examined using slit lamp examination and fundus photography
of each eye through dilated pupils.
Results: A sample of 513 diabetic patients was selected with a mean age of 53 years (SD ± 13.01).
Retinopathy was present in 19% (95% CI: 15.1–23.5%) of the study population. Most patients (74%)
were not aware of their condition. The disease was more common among males (24.2 vs. 13.9%;
p = 0.016), increased with increasing age (p = 0.004) and disease duration (p = 0.0001). Type I DM
was a highly significantly contributing risk factor (38.3% for type 1, vs. 16.4%   for type 2; p <
0.0001). Retinopathy was higher among patients with hypertension, microalbuminuria, peripheral
vascular disease, coronary artery disease and neuropathy.
Conclusion: The prevalence of DR in the UAE was (19%) and significantly affected elderly males.
Regular screening to detect DR is highly recommended as with the early detection of proliferative
retinopathy and timely laser photocoagulation which are known to prevent most of the diabetes
related blindness.
Background
Diabetic retinopathy (DR) is a complication of diabetes
mellitus (DM) that affects the blood vessels of the retina
and leads to blindness. The progression of retinopathy is
gradual, advancing from mild abnormalities, character-
ized by increased vascular permeability, to moderate and
severe non-proliferative diabetic retinopathy, character-
ized by the growth of new blood vessels on the retina and
posterior surface of the vitreous [1].
DR is one of the most serious complications of diabetes.
For example, the Wisconsin epidemiological study of dia-
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diagnosed with type 1, and 1.6% of those diagnosed with
type 2 DM were legally considered blind. For type 1 DM,
blindness was mostly (86%) due to diabetic retinopathy.
For type 2 DM, blindness was related to retinopathy in
33% of the cases [2]. The prevalence of DR is probably
around 30% in type 2 DM, but notably was above this
level in five out of six studies reported from the Asian and
pacific island nations of the Western Pacific Region [3].
The annual incidence of retinopathy requiring opthalmo-
logical follow up or treatment has been reported to aver-
age 1.5% after one year [4]. The same source estimates
that 6–9% of patients with proliferative retinopathy or
severe non proliferative disease would become blind each
year [4]. Moreover, growing evidence also suggests that
after 15 years of diabetes, approximately 2% of patients
develop blindness, while about 10% develop severe visual
handicap [4]. Thus, the early detection of sight-threaten-
ing retinopathy and the timely intervention with laser
photocoagulation has been shown to be effective in pre-
venting severe visual loss.
Several factors have been identified as determinants for
the development of DR and its progression; including,
type and duration of DM, age, gender, glycemic control,
hypertension, body mass index (BMI), smoking, serum
lipids and presence of microalbuminuria (MA) [[5-8] and
[9]].
Despite the potential risk of DM complications in general
and the grave burden imposed by DR in particular, no
study was carried before to estimate the impact of the
problem in the UAE. To our best knowledge this effort
constitutes the first attempt to estimate the prevalence and
determinants of DR among diabetics in Al-Ain district,
UAE, with the specific objective of identifying high risk
groups for DR amendable to timely intervention, in order
to facilitate the planning of screening services. Al Ain city
is located in the interior of Abu Dhabi Emirate and consti-




The study was part of a general cross-sectional survey of
DM patients carried out to assess and establish the preva-
lence of DM complications including retinopathy among
diabetic patients in Al-Ain District, UAE during 2003/
2004.
Subjects and setting
Multi-stage random sampling was used to select 8 primary
health care centers (PHC) in Al-Ain district (out of 22
rural and urban health care centers) in addition to two
diabetic clinics in the only two governmental hospitals in
the district (Tawam and Al-Ain hospitals). Thus, our sam-
pling frame included all UAE national and non-national
DM patients (types 1 and 2) of all ages of both genders,
attending any of the selected primary health care centers
(PHC) for any reason and diabetic clinics at the two hos-
pitals for follow up. Within these primary sampling units
(PHC and hospital clinics), a systematic random sam-
pling was carried out to select a sub-sample of patients to
be approached for participation in the study. In the
absence of a computerized database in the UAE every
third diabetic patient was approached to participate dur-
ing the study period. A sample size of 625 was calculated
to give a standard error in the prevalence of retinopathy of
less than 2%. In total 600 patients were contacted by gen-
eral practitioners and diabetologists, out of which, 513
patients (86%) agreed to enroll. The study was approved
by the ethical committee of the Faculty of Medicine and
Health Sciences of the UAE University.
Data collection
After receiving informed consent, known diabetic patients
in Al-Ain were interviewed by the treating doctors at PHC
and hospital clinics and information pertinent to their
DM type, duration, compliance with treatment as assessed
by doctors, associated complications and co-morbidity
was collected. Additionally, blood pressure was measured
by the PHC/hospital nurse early in the morning and prior
to drawing blood samples in the sitting position, using a
standard mercury sphygmomanometer. Height was meas-
ured without shoes, and weight recorded while wearing
indoor clothing. Body mass index (BMI) (weight in Kg,
divided by height in meters squared) was calculated. The
WHO (1977, 1979) classification for BMI was used to esti-
mate the degree of obesity [10]. Fasting blood samples
were taken to assess lipid profile, blood sugar and glycated
hemoglobin (HbA1C) levels. Total lipid profile (total cho-
lesterol (TC), high density lipoprotein (HDL), TC/HDL
Ratio, low density lipoprotein (LDL) and triglycerides)
were measured by a capillary tube whole blood method
using the Cholesterol LDX lipid analyzer. Dyslipidaemia
was taken to be present when the total cholesterol was >
5.60 mmol/L and/or triglycerides > 2.10 mmol/L, LDL >
3.4 mmol/L, and or HDL < 0.91 mmol/L [11]. Glycated
hemoglobin (HbA1C) was measured using the Bayer DCA
2000+ analyzer and a value of less than 7% was taken to
indicate good glycemic control. A standard 12- lead elec-
trocardiogram (ECG) was recorded for all patients. The
WHO definition of hypertension was used in this study:
systolic blood pressure 160 mmHg or more and/or a
diastolic blood pressure 95 mmHg or more, or on going
treatment with antihypertensive drugs. MA was assessed
using semi-quantitative dry immuno chemical screening
strips (Micral 11 ® test strips (Roche diagnostic GmbH
Mannheim Germany). Micral Tests were performed onPage 2 of 8
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more than 20 µg/min was judged as pathological.
All patients were referred to two ophthalmologists work-
ing at the two main hospitals of Al-Ain district and under-
went detailed eye examination. After adequate mydriasis,
the examination of the interior segment was carried out
using Haag Streit slit lamp 900BQ with stereovariator. The
intraocular pressure was measured using applanation
tonometry. Fundus photography operating with a digital
camera (Super 66 equipped with stereo fundus lens).
Diabetic retinopathy was classified using Watkins et al
(2003) standards, and as follows: i) background retinop-
athy, if microaneurysms, haemorrhages (dot, blot or
flamed shaped) or hard exudates and/or macular edema
were present; ii) proliferative diabetic retinopathy, if cot-
ton wool spots, multiple large blot haemorrhage, neovas-
cularisation of the retina or iris, angle, venous beading,
loops, and reduplication, arterial sheathing or atrophic
looking retina were present; and iii) advanced diabetic eye
disease, if vitreous haemorrhage, retinal detachment or
rubeosis iriditis or glaucoma was present [12].
According to standard practice, dense cataract and blind
patients with diabetes were also considered to have dia-
betic ophthalmopathy whenever it was impossible to
establish the cause of their blindness. The severity of retin-
opathy was determined by the grading of the most seri-
ously affected eye.
Statistical analysis
The data was coded and processed on IBM compatible
computers, using the Statistical Package for Social Sci-
ences (SPSS) software (version 13). Descriptive analysis,
using standard statistical methods was performed. Chi-
square tests and Fisher exact tests were used to ascertain
the association between retinopathy and clinical varia-
bles. The Mantel-Haenszel test was used to adjust relation-
ships between categorical variables for dichotomous
confounders, while logistic regression was used to esti-
mate the simultaneous effect of several determinants on a
dichotomous (yes/no) outcome.
Results
Socio-demographic characteristics of the study population
A total sample (n = 513) of diabetic patients of both gen-
der and from all nationalities (UAE nationals and expatri-
ates) resident in the Al-Ain district of Abu Dhabi emirate
was selected. Of those, 52% were males, 27% were aged
60 years or above (mean age 53.3), 75% were UAE nation-
als and most patients (63%) were illiterate (Table 1). The
data were collected between September 2003 and May
2004.
Clinical characteristics
Of the total sample, the majority (86%) had type 2 DM,
49% had been diagnosed incidentally and most of them
(79%) had the disease for ≥ 10 years. Of the total sample
35% (95% C.I.: 30.8–39) had hypertension and 76%
were obese or overweight.The analysis of glycemic control
(HbA1C) showed that 38% (95%CI: 32.8–42.4) had good
control (less than 7%), while it was poor in 62% (95%CI:
57.6–67.2). Dyslipidaemia, assessed by elevated total
cholesterol, was present in 34.4% (95%CI: 30.0–38.8),
and elevated triglycerides was present in 25.2% (95%CI:
21.1–29.3) (Table 2). Of the total sample, 12.8% (95%CI:
11.0–14.6) were current smokers while 8.2% (95%CI:
6.7–9.7) were ex-smokers.
Prevalence of retinopathy
Of the total study population, retinopathy was present in
19% (95% CI: 15.1–23.5). Only 1.5 % (5 cases) of the
study sample were presumptive diagnosis due to the pres-
ence of cataract or blindness. Most patients detected with
diabetic retinopathy (74%) were not aware of their eye
condition before the survey. Of the total study sample,
background retinopathy was present in 13.8%, prolifera-
tive retinopathy in 3.8% and advanced eye disease in only
Table 1: Socio-Demographic   Characteristics of DM Patients in 
Al-Ain District, UAE, 2003-2004  (n=513)
Variable name Prevalence of DM
n Percent (95% CI)
Sex
Male 264 51.5 (47.2–55.8)
Female 249 48.5 (44.2–52.8)
Level of Education
Illiterate 318 62.8 (58.6–67.0)
Completed primary school 99 19.6 (16.1–23.1)
Completed secondary school 60 11.9 (9.1–14.7)
Completed university 29 5.7 (3.7–7.7)
Age group (Years)
40 or less 81 15.8 (12.6–19.0)
41 – 49 137 26.8 (23–30.6)
50 – 59 154 30.1 (26.1–34.1)
60 or above 140 27.3 (23.4–31.2)
Nationality Group
UAE 382 74.6 (70.8–78.4)
Other GCC citizens 54 10.5 (7.8–13.2)
Arabs from other countries 54 10.5 (7.8–13.2)
Asians 22 4.3 (2.5–6.1)
BMI Group
Under weight 6 1.2 (0.2–2.2)
Healthy weight 113 22.5 (18.8–26.2)
Overweight and obese 383 76.3 (72.6–80.0)Page 3 of 8
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more common among males (24.7%) than females
(13.9%) (p = 0.02). DR was significantly higher among
type 1 DM patients (38.3%) compared to type 2 DM
patients (16.4%) (p = < 0.001). The complication
increased with increasing age (p < 0.01) and disease dura-
tion (p < 0.001) (Tables 3 and 4). Hypertension was mar-
ginally significantly associated with retinopathy (p =
0.07), but this was weakened somehow when adjusted for
sex, age, and duration of disease (logistic regression
adjusted OR 1.54, 95% CI 0.82–2.89). Microalbuminuria
was significantly associated with diabetic retinopathy (p <
0.001), after adjustment for sex, age, and duration (logis-
tic regression adjusted OR 2.04, 95% CI 1.03–4.07). The
disease was statistically significantly associated with other
chronic DM complications such as: i) peripheral neurop-
athy (p = 0.001), however, the association was only mar-
ginally statistically significant when adjusted for sex and
duration of disease (logistic regression adjusted OR 1.70
95% CI 0.90–3.21); ii) coronary artery disease (p =
0.002), but again was only marginally statistically signifi-
cant when adjusted for sex and duration of disease
(adjusted OR 1.96 95% CI 0.91–4.22); and, iii) peripheral
vascular disease (p = 0.009), however, this effect disap-
peared when adjusted for sex and duration of disease
(Table 5). There was no significant association of DR with
cerebrovascular disease, neither univariately, nor multi-
variately, but this may be due to the rarity of this condi-
tion in the sample population (3.5%). BMI, glycemic
control, smoking and dyslipidaemia were not statistically
associated with DR.
In a multivariate stepwise logistic regression (with back-
ward selection of variables) of retinopathy on age, sex,
duration of diabetes and hypertension, only the female
gender (adjusted OR 0.573, 95% CI 0.297–1.107), age
(adjusted OR 1.029 per year; 95% CI 01.002–1.056), type
of DM (adjusted OR for type 2 0.468, 96%CI 0.198–
1.103) and, duration of DM (adjusted OR 1.013 per year,
95% CI 1.008–1.018) were found to be (marginally) sig-
nificantly associated with retinopathy.
Discussion
The International Diabetes Federation (IDF) in 2003
ranked the UAE's prevalence rates for type 2 DM and
impaired glucose tolerance (IGT) as the second highest in
the world (20% for DM and 26% for IGT) [3] implying
that the disease and its complications such as retinopathy
might constitute a sizable health care burden to the UAE
population. Despite that, little is known about the true
impact of DM and its complications, including diabetic
retinopathy, in the UAE population. While the prevalence
Retinopathy among   DM Patients in Al-Ain District, UAE, 2003-2004 (n=347)Figure 1












Table 2: Clinical Characteristics of DM Patients in Al-Ain 
District, UAE, 2003-2004 (n=513)
Variable name Prevalence of DM
n Percent (95% CI)
Type of DM
Type 1 68 13.6 (10.6–16.6)
Type 2 431 86.4 (83.4–89.4)
Mode of Diagnosis
Incidental 245 48.5 (44.1–52.9)
Screening 39 7.7 (5.4–10.0)
Symptomatic 221 43.8 (39.5–48.1)
Family History of DM
Present 270 54.3 (49.9–58.7)
Absent 227 45.7(41.3–50.1)
Duration of the DM
< 1 year 33 6.6 (4.4–8.8)
1–5 years 199 40.0 (35.7–44.3)
6–10 years 161 32.3 (28.2–36.4)
11–20 years 98 19.7 (16.2–23.4)
> 21 years 7 1.4 (0.4–2.4)
Hypertension
Present 178 34.9 (30.0–38.8)
Absent 332 65.1(61.0–69.2)
Dyslipidaemia
High total cholesterol level 152 34.4 (30.0–38.8)
Within the reference range 290 65.5(61.1–69.9)
Triglycerides
Elevated triglycerides 105 23.9 (19.9–27.9)





Good control 150 37.6(32.8–42.4)
Poor control 249 62.4(57.6–67.2)Page 4 of 8
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reported in other populations such as the US (40–45 %
[13]), Saudi Arabia (31%), Oman (42%) and Egypt
(42%) [14,15] and [16], it was substantially higher than
the equivalent rate reported in a similar study in Kuwait
(8%) [17]. The substantial heterogeneity in reported prev-
alence of retinopathy may partly be real, for example due
to differences in the age structure of different population,
but may also be due to differences in study methodology
and population sample.
Our findings clearly demonstrate that, as elsewhere, DR is
a common health problem and may well be among the
leading causes of blindness in UAE adults. It is well estab-
lished that nearly all patients with DM – of both type 1
and type 2 – are at high and increasing risk for the disease
[2,13]. The fact that the majority of our study population
(63%) were illiterate further reveal and emphasize the
seriousness and complexity of the problem in the UAE.
Therefore, additional care needs to be taken to illiterate
patients to have a comprehensive annual eye examination
with pupil dilation while treating doctors should also be
reminded to closely follow DM treatment guidelines and
refer all diabetics to ophthalmologist for management
and treatment as indicated to preserve vision.
The analysis of the sample population showed that DR
increases with patients' age and disease duration, which is
consistent with findings elsewhere [5,6,11,12], and [18].
Comparatively, the duration of diabetes is known to
reflect total glycemic control and risk factors exposure
over time [2,18]. While this may suggest avenues for pri-
mary prevention, the true prospects for that are currently
unknown. For example, Aiello et al [13] in a longitudinal
study have shown that after 20 years duration, nearly all
type 1 DM patients and approximately two thirds of type
2 DM end up developing retinopathy regardless of their
diabetic control. However, the analysis revealed that DR
in the study sample was marginally significantly associ-
ated with hypertension, which is largely held as a signifi-
cant risk factor in most studies [7,19]. Thus, improved
monitoring and control of hypertension among DM
patients in the UAE, which has always been shown to slow
the progression of retinopathy, particularly among those
Table 3: Diabetic Retinopathy in   relation to Sociodemographic Characteristics of DM Patients in Al-Ain   District, UAE, 2003-2004 
(n=513)
Variable name Presence of DR Absence of DR
n Percent (95% CI) n Percent (95% CI) p-value
Sex 0.016
Male 44 24.2(13.9–34.5) 138 75.8(70.8–80.8)
Female 23 13.9(5.6–22.2) 142 86.1(82.0–90.2)
Level of Education 0.147
Illiterate 43 20.6(10.8–30.4) 166 79.4(74.7–84.1)
Completed primary school 8 12.1(4.2–20.0) 58 87.9(84.1–91.7)
Completed secondary school 13 26.5(15.9–37.1) 36 73.5(68.3–78.7)
Completed university 2 9.5(2.4–16.6) 2 90.5(87.1–93.9)
Age group (Years) 0.004
40 or less 5 9.3(2.3–16.3) 49 90.7(87.3–94.1)
41 – 49 15 15.0(6.4–23.6) 85 85.0(80.8–89.2)
50 – 59 18 18.2(9.0–27.4) 81 81.8(77.3–86.3)
60 or above 29 31.2(20.1–42.3) 64 68.8(63.4–74)
Nationality group 0.005
UAE 49 19.7(10.2–29.2) 200 80.3(75.6–85.0)
Other GCC citizens 2 5.9(0.3–11.5) 32 94.1(91.3–96.9)
Arabs from other countries 7 15.9(7.1–24.7) 37 84.1(79.8–88.4)
Asians 9 45.0(33.1–56.9) 11 55.0(49.2–60.8)
BMI Group 0.166
Under weight 2 50.0(38.0–62.0) 2 50.0(44.1–55.9)
Healthy weight 17 23.9(13.7–34.1) 54 76.1(71.1–81.1)
Overweight and Obese 48 18.0(8.8–27.2) 218 82.0(77.5–86.5)Page 5 of 8
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Table 4: Diabetic Retinopathy in   relation to Clinical Characteristics of DM Patients in Al-Ain District, UAE,   2003-2004 (n=513)
Variable name Presence of DR Absence of DR
n Percent (95% CI) n Percent (95% CI) p-value
Type of DM 0.000
Type 1 18 38.3(26.6–50.0) 29 61.7(55.9–67.5)
Type 2 48 16.4(7.5–25.3) 244 83.6(79.2–88.0)
Mode of Diagnosis 0.596
Incidental 35 21(11.1–30.9) 132 79.0(74.2–83.8)
Screening 3 13(4.8–21.2) 20 87.0(83.0–91.0)
Symptomatic 27 18(8.7–27.3) 123 82.0(77.5–86.5)
Family History of 
DM
0.282
Present 32 17.2(8.0–26.4) 154 82.8(78.3–87.3)
Absent 33 21.9(11.8–32.0) 118 78.1(73.2–83.0)
Duration of the DM 0.000
< 1 year 1 4.5(0–9.5) 21 95.5(93.0–98.0)
1–5 years 9 6.7(0.6–12.8) 126 93.3(90.3–96.3)
6–10 years 17 16.5(7.5–25.5) 86 83.5(79.1–87.9)
11–20 years 36 52.2(40.1–64.3) 33 47.8(41.8–53.8)
> 21 years 2 33.3(21.8–44.8) 4 66.7(61.1–72.3)
Hypertension 0.050
Present 31 25.0(14.6–35.4) 93 75.0(69.9–80.1)
Absent 36 16.3(7.5–25.1) 185 83.7(79.4–88.0)
Dyslipidaemia 0.936
High total cholesterol 
level
22 20.0(10.2–29.8) 88 80.0(75.1–84.9)
Within the reference 
range
42 19.6(9.9–29.3) 172 (75.6–85.2)
Triglycerides 0.500
Elevated triglycerides 14 17.1(7.8–26.4) 68 82.9(78.3–87.5)
Within reference 
range
49 20.5(10.5–30.5) 190 79.5(74.6–84.4)
Microalbuminuria
Negative 27 23.5(12.3–34.7) 88 76.5(71.2–81.8) 0.073
Positive 28 15.2(5.7–24.7) 156 84.8(80.3–89.3)
HbA1C 0.556
Good control 21 36.2(23.8–48.6) 97 40.4(34.2–46.6)
Poor control 37 63.8(51.4–76.2) 143 59.6(53.4–65.8)
Table 5: Diabetic Retinopathy in   relation to Systemic Diseases among DM Patients in Al-Ain District, UAE,   2003-2004 (n=513)
Associated Systemic Diseases Diabetic Retinopathy
Present (n = 67) Absent (n = 280)
Type N (%) n n Adjusted OR 95% CI
Microalbuminuria 276(61.2%) 28 156 2.04 (1.03–4.07)
Hypertension 178(34.9%) 31 93 1.54 (0.82–2.89)
Peripheral Neuropathy 199(38.8%) 35 80 1.70 (0.90–3.21)
Coronary Artery Disease 73(14.2%) 18 33 1.96 (0.91–4.22)
Peripheral Vascular Disease 59(11.5%) 16 32 1.19 (0.52–2.75)
BMC Ophthalmology 2007, 7:11 http://www.biomedcentral.com/1471-2415/7/11with poorly controlled diabetes, is strongly recommended
[20].
As reported elsewhere, the presence of microalbuminuria
was highly significantly associated with DR in the study
population (OR 2.04; 95% CI: 1.03–4.07). MA is a well
known predictor for diabetes cardiovascular complica-
tions and therefore, DM patients should be targeted for
screening for early detection and treatment [21,22].
The prevalence of retinopathy was also higher in DM
patients with other chronic DM complications such as
coronary artery disease (p = 0.002), peripheral neuropa-
thy (p = 0.001) and peripheral vascular disease (p =
0.009). However, a multivariate stepwise logistic regres-
sion analysis on these chronic complications showed only
marginal significant association after adjusting for sex and
duration which is consistent with studies in the neighbor-
ing countries such as Sultanate of Oman [23]. Surpris-
ingly, and unlike findings elsewhere [18], the degree of
glycemic control did not show any significant association
with DR in the study sample.
Our study has few limitations. First, the assumption that
DM patients with blindness and cataract had diabetic
retinopathy as the primary cause, may have slightly led to
some over estimation of the prevalence of retinopathy.
Second, it is known that DM is notoriously under-diag-
nosed, and therefore while our sample probably ade-
quately reflects DR among diagnosed DM patients; it is
likely that this proportion still reflects only the top of the
iceberg.
Conclusion
Our study documented for the first time the prevalence,
type and determinants of diabetic retinopathy in the UAE.
This complication was related to the patient's age, male
gender, type of DM, disease duration and presence of
hypertension, MA and other chronic complications of dia-
betes. As such it is important to recommend introducing
early screening program for DR for all diabetic patients,
and especially those with associated hypertension, micro-
albuminuria and those with long disease duration.
Notwithstanding that the rate of DM in the population is
high, and the fact that a high rate of undiagnosed diabetes
exits in the UAE, it is highly recommended that urgent
efforts should be made to improve health education to
DM patients. It is established that the knowledge of the
retinopathy status of an individual is just one in a whole
process of care in diabetes. The implicit 'gold standard' for
identifying and grading retinopathy remains, the retinal
examination by the ophthalmologist. Several studies
[2,24] have demonstrated the cost effectiveness of screen-
ing for retinopathy and established that screening for DR
saves vision at a relatively low cost; much lower and safe
than with later interventions like involving intra-ocular
surgery in the absence of a screening program. Equally,
the enormous potential debilitating indirect costs of retin-
opathy on patients could be curbed with increased pro-
ductivity and decreased disability. Much awareness,
management and attention to the complication is there-
fore needed in the UAE.
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